IDEXX Laboratories Inc
NASDAQ:IDXX
IDEXX Laboratories Inc
Cash from Investing Activities
IDEXX Laboratories Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
Cash from Investing Activities
-$192.7m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-9%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Investing Activities
-$658m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
4%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Investing Activities
-$2.4B
|
CAGR 3-Years
-108%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-16%
|
|
Stryker Corp
NYSE:SYK
|
Cash from Investing Activities
-$1.2B
|
CAGR 3-Years
36%
|
CAGR 5-Years
12%
|
CAGR 10-Years
6%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Investing Activities
-$3.1B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-3%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Investing Activities
-$1.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
See Also
What is IDEXX Laboratories Inc's Cash from Investing Activities?
Cash from Investing Activities
-192.7m
USD
Based on the financial report for Mar 31, 2024, IDEXX Laboratories Inc's Cash from Investing Activities amounts to -192.7m USD.
What is IDEXX Laboratories Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-9%
Over the last year, the Cash from Investing Activities growth was 0%. The average annual Cash from Investing Activities growth rates for IDEXX Laboratories Inc have been -32% over the past three years , -4% over the past five years , and -9% over the past ten years .